Amarin Corp Plc (AMRN)

[ziploc_1]

Announcement of a timely ANDA submission to the FDA for a combo statin-Vascepa product(e.g. 20 mgms of statin combined with 1 gm of Vascepa) would help Amarin to reclaim its rightful U.S. market for branded Vascepa. Many patients with CVD are on multiple meds and taking one less med would be appreciated.

For those patients, who need a lower dose of a statin, a combo with 10 mgs of a Statin and 1 gm Of Vascepa could also be made available.